Related Experiment Videos
Pathogenesis and consequences of HIV-associated wasting
1Department of Medicine, Tufts University School of Medicine, Boston, MA 02111, USA. Christine.wanke@tufts.edu
Journal of Acquired Immune Deficiency Syndromes (1999)
|February 22, 2005
Summary
Significant weight loss in HIV patients indicates a poor prognosis, with even minor losses correlating to increased mortality. HIV wasting involves metabolic issues and can be worsened by poor nutrition and gastrointestinal problems.
Area of Science:
- Infectious Diseases
- Metabolic Disorders
- Clinical Medicine
Background:
- Weight loss is a critical negative prognostic indicator in Human Immunodeficiency Virus (HIV) infection.
- Mortality rates increase with even minor weight loss (3-5%) over six months.
- HIV-associated wasting shares characteristics with cachexia seen in infections, trauma, and cancers.
Purpose of the Study:
- To explore the multifaceted nature of weight loss in HIV patients.
- To differentiate HIV-associated wasting from other forms of cachexia.
- To identify contributing factors beyond abnormal energy expenditure.
Main Methods:
- Analysis of prognostic indicators in HIV-infected patients.
- Correlation of weight loss with metabolic cachexia.
- Investigation of factors contributing to HIV wasting, including caloric intake and gastrointestinal function.
Main Results:
- Weight loss is a sensitive marker for increased mortality in HIV.
- HIV wasting may result from reduced caloric intake, gastrointestinal dysfunction, or metabolic abnormalities.
- Factors independent of abnormal energy expenditure contribute to HIV wasting.
Conclusions:
- Therapeutic strategies for HIV wasting must address the root causes of protein-energy malnutrition.
- Interventions should also target other contributing factors like gastrointestinal dysfunction and metabolic abnormalities.
- Comprehensive management is crucial for improving outcomes in HIV patients experiencing weight loss.